S4–04–02: M1 muscarinic agonists as a comprehensive therapy in Alzheimer's disease

Autor: Antonela Caccamo, Abraham Fisher, Kim N. Green, Rachel Brandeis, Hanoch Elkon, Z. Pittel, Lauren M. Billings, Salvatore Oddo, Nira Bar-Ner, Frank M. LaFerla
Rok vydání: 2006
Předmět:
Zdroj: Alzheimer's & Dementia. 2
ISSN: 1552-5279
1552-5260
DOI: 10.1016/j.jalz.2006.05.285
Popis: contextual memory was also measured. Conclusions: We have identified a number of development candidates aimed at targeting either improved symptomatic therapy or disease slowing. This ‘multiple shots on goal’ approach using multiple platforms and multiple targets will help to increase the likelihood of delivering novel therapeutics to patients. Ultimately, the success of our programs, will be judged by our ability to deliver novel therapies to patients with significant positive impact on their lives, and a slowing, halting or perhaps even reversing of this devastating disease process.
Databáze: OpenAIRE